Healthcare provider profile · identity verified

John J Kunstle, MD

Family Practice · COLORADO SPRINGS, CO · NPI 1104881978

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	386	110
Levothyroxine Sodium	Levothyroxine Sodium	336	99
Lisinopril	Lisinopril	234	68
Omeprazole	Omeprazole	200	60
Metformin Hcl	Metformin Hcl	189	59
Metoprolol Succinate	Metoprolol Succinate	177	46
Amlodipine Besylate	Amlodipine Besylate	174	56
Losartan Potassium	Losartan Potassium	156	46
Tamsulosin Hcl	Tamsulosin Hcl	138	44
Gabapentin	Gabapentin	135	38
Rosuvastatin Calcium	Rosuvastatin Calcium	101	35
Allopurinol	Allopurinol	98	24
Furosemide	Furosemide	94	29
Pioglitazone Hcl	Pioglitazone Hcl	91	25
Albuterol Sulfate Hfa	Albuterol Sulfate	90	38
Potassium Chloride	Potassium Chloride	86	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	82	16
Pantoprazole Sodium	Pantoprazole Sodium	81	25
Alendronate Sodium	Alendronate Sodium	79	20
Trazodone Hcl	Trazodone Hcl	77	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	76	suppressed
Simvastatin	Simvastatin	75	23
Prednisone	Prednisone	73	52
Ipratropium Bromide	Ipratropium Bromide	71	39
Pravastatin Sodium	Pravastatin Sodium	66	20
Hydrochlorothiazide	Hydrochlorothiazide	59	18
Escitalopram Oxalate	Escitalopram Oxalate	53	18
Sertraline Hcl	Sertraline Hcl	51	15
Carvedilol	Carvedilol	49	16
Eliquis	Apixaban	46	13
Oxycodone Hcl	Oxycodone Hcl	46	suppressed
Finasteride	Finasteride	44	16
Donepezil Hcl	Donepezil Hcl	43	suppressed
Metformin Hcl Er	Metformin Hcl	43	11
Duloxetine Hcl	Duloxetine Hcl	42	12
Metoprolol Tartrate	Metoprolol Tartrate	42	13
Montelukast Sodium	Montelukast Sodium	42	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	39	14
Tramadol Hcl	Tramadol Hcl	39	14
Famotidine	Famotidine	38	14
Lorazepam	Lorazepam	38	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	38	12
Fluoxetine Hcl	Fluoxetine Hcl	37	12
Warfarin Sodium	Warfarin Sodium	36	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	35	suppressed
Lovastatin	Lovastatin	33	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	11
Bupropion Xl	Bupropion Hcl	29	suppressed
Xarelto	Rivaroxaban	28	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	27	suppressed
Fenofibrate	Fenofibrate	27	suppressed
Jardiance	Empagliflozin	27	suppressed
Propranolol Hcl Er	Propranolol Hcl	27	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	26	suppressed
Ozempic	Semaglutide	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	11
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	22	20
Glipizide	Glipizide	22	suppressed
Atenolol	Atenolol	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Raloxifene Hcl	Raloxifene Hcl	19	suppressed
Alprazolam	Alprazolam	18	suppressed
Cefuroxime	Cefuroxime Axetil	18	16
Doxepin Hcl	Doxepin Hcl	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	12
Benazepril Hcl	Benazepril Hcl	17	suppressed
Clonazepam	Clonazepam	17	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Testosterone	Testosterone	17	suppressed
Dutasteride	Dutasteride	16	suppressed
Estradiol	Estradiol	16	suppressed
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Valsartan	Valsartan	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Baclofen	Baclofen	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	11
Ezetimibe	Ezetimibe	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Topiramate	Topiramate	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Alprazolam Er	Alprazolam	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Prazosin Hcl	Prazosin Hcl	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error